HDFC NIFTY MIDCAP 150 INDEX FUND vs HDFC Pharma and Healthcare Fund

Portfolio Overlap Analysis · HDFC vs HDFC

5.3%
Low Overlap
6 common stocks · Rank #27738 of 28,292 pairs
Fund A
HDFC NIFTY MIDCAP 150 INDEX FUND
HDFC · Mid Cap
Fund B
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma

Common Holdings (6)

StockWt% in HDFC NIFTY MIDCAP 150 INDEXWt% in HDFC Pharma and HealthcareOverlap
Lupin Ltd.
Pharmaceuticals & Biotechnology
1.47%6.44%1.47%
Fortis Healthcare Limited
Healthcare Services
1.30%4.02%1.30%
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
0.87%6.21%0.87%
Glenmark Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
0.85%6.62%0.85%
Ipca Laboratories Ltd.
Pharmaceuticals & Biotechnology
0.56%4.80%0.56%
Global Health Limited
Healthcare Services
0.25%1.84%0.25%

Unique to HDFC NIFTY MIDCAP 150 INDEX

  • Bombay Stock Exchange Limited (BSE)2.92%
  • Hero MotoCorp Ltd.1.95%
  • The Federal Bank Ltd.1.95%
  • Cummins India Ltd.1.75%
  • Indusind Bank Ltd.1.66%
  • Ashok Leyland Ltd1.59%
  • Indus Towers Limited1.55%
  • HDFC Asset Management Company Ltd.1.45%
  • Au Small Finance Bank Ltd.1.43%

Unique to HDFC Pharma and Healthcare

  • Sun Pharmaceutical Industries Ltd.9.81%
  • Divis Laboratories Ltd.8.38%
  • Max Healthcare Institute Limited6.36%
  • Aster DM Healthcare Limited5.42%
  • Anthem Biosciences Limited4.46%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
3.8% (4)
Healthcare Services
1.6% (2)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC NIFTY MIDCAP 150 INDEX

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.